retatrutide clinical trial weight loss results 2024 2025 press release Lilly's retatrutide shows 28% weight loss Survodutide vs. Retatrutide for Weight

Research shows that, on average, p eople regain about 14% of the weight they lost after stopping tirzepatide , the active ingredient in Zepbound

While traditional therapies such as statins suppress the functioning of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, recent attention has turned toward GLP-1 RAs effects on modulating lipid profiles

doi: 10.1124/pr.115.011395 55 KnaufCAbotAWemelleECaniPD

Inform your healthcare provider if you experience neck swelling, hoarseness, difficulty swallowing, or shortness of breath

Licensed, NICE-approved alternatives for weight management including semaglutide (Wegovy) and tirzepatide (Zepbound) are available through NHS and regulated private UK healthcare pathways